Association of Halo Nevus/i and Vitiligo in Childhood: a Retrospective Observational Study
Overview
Authors
Affiliations
Background: Although halo nevus (HN) is frequently observed, the relationship between vitiligo and HN in children has rarely been investigated.
Objectives: To investigate the association between HN and vitiligo in children and understand if HN/HNi might be a risk factor for vitiligo.
Methods: Ninety-eight patients with only HN/HNi and 27 with HN/HNi and vitiligo were investigated for number and localization of HN/HNi, family history for HN/HNi and vitiligo and personal and family history for autoimmune or other diseases. A follow-up telephone interview was performed to investigate the evolution of HN/HNi and the possible onset of vitiligo and/or other diseases.
Results: In the HN/HNi and vitiligo group, HN/HNi and vitiligo had started almost simultaneously in 11 children; in nine, the onset of HN/HNi was followed by vitiligo after 6 months to 5 years; seven patients presented vitiligo first and HN/HNi after 3-9 years. Patients with associated vitiligo had, significantly more often, multiple HNi and a positive personal and/or family history of autoimmune thyroiditis compared with those with only HN/HNi. Follow-up longer than 5 years was available in 54/98 patients with only HN/HNi; two of them, both with multiple HNi, developed vitiligo. After follow-up, multiple HNi were noticed in 18/52 patients without vitiligo and in 9/11 of those in whom HN/HNi heralded vitiligo (s.s.).
Conclusions: In patients with multiple HNi, the risk of vitiligo and other autoimmune diseases seems to be higher than in pediatric patients with a single HN; clinicians should pay particular attention to children with multiple HNi and personal or family history of autoimmune diseases.
Current Challenges in Deciphering Sutton Nevi-Literature Review and Personal Experience.
Nedelcu R, Dobre A, Brinzea A, Hulea I, Andrei R, Zurac S J Pers Med. 2021; 11(9).
PMID: 34575681 PMC: 8470687. DOI: 10.3390/jpm11090904.
Melanoma and Vitiligo: In Good Company.
Failla C, Carbone M, Fortes C, Pagnanelli G, DAtri S Int J Mol Sci. 2019; 20(22).
PMID: 31731645 PMC: 6888090. DOI: 10.3390/ijms20225731.
Tattoo pigment removal by halo nevus phenomenon.
Dodgen T, Crowe D JAAD Case Rep. 2019; 5(4):317-318.
PMID: 30976642 PMC: 6441708. DOI: 10.1016/j.jdcr.2018.05.027.
Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients.
Fleissig E, Pavlovksy M, Loewenstein A, Zur D, Newman H, Keren S Graefes Arch Clin Exp Ophthalmol. 2018; 256(5):927-933.
PMID: 29549426 DOI: 10.1007/s00417-018-3958-0.
Factors Associated with Development of Vitiligo in Patients with Halo Nevus.
Zhou H, Wu L, Chen M, Liao Q, Mao R, Han J Chin Med J (Engl). 2017; 130(22):2703-2708.
PMID: 29133759 PMC: 5695056. DOI: 10.4103/0366-6999.218011.